Omada Health, Inc. OMDA
19.66
(0.06)
(0.30%)
as of 25 Sep
- Market cap
- $1.2B
- P/E
- 281×
Follow OMDA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 1.84% | 8.38% | 0.00% | 0.00% |
+6 more TTM periods Free account |
|
| 1.36% | (4.16%) | (8.37%) | (18.90%) | ||
ROIC |
(0.93%) | (23.37%) | (97.89%) | (79.39%) | |
Return on Tangible Assets |
1.88% | (3.01%) | (6.23%) | (14.12%) | |
Average Days of Receivables |
66.66 | 51.52 | 48.51 | 65.81 | |
Free Cash Flow per Share |
0.29 | 0.28 | 0.34 | (0.26) | |
Free Cash Flow |
17.13 | 16.40 | 12.42 | (15.07) | |
Capital Expenditures |
(6.55) | (6.14) | (5.83) | (5.45) | |
Piotroski F-Score |
6.00 | 1.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
4.99% | 5.05% | 4.04% | (2.31%) | |
Accounts Receivable Turnover |
6.89 | 8.94 | 0.00 | 0.00 | |
Accounts Payable Turnover |
10.26 | 15.58 | 0.00 | 0.00 | |
Inventory Turnover |
25.97 | 26.82 | 0.00 | 0.00 | |
Average Days of Payables |
43.72 | 30.94 | 42.02 | 23.21 | |
Days of Inventory on Hand |
15.26 | 14.63 | 18.34 | 13.67 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
15.88% | 15.73% | 15.63% | 16.52% | |
Selling, General and Administrative Expense of Revenue |
52.46% | 53.48% | 54.66% | 57.26% | |
Share Based Compensation of Revenue |
5.53% | 5.05% | 4.98% | 4.95% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
5.50 | (3.58) | (1.43) | 0.35 | |
Depreciation/Fixed assets |
1.06 | 1.11 | 1.15 | 1.18 | |
Capex/Depreciation |
(0.68) | (0.65) | (0.64) | (0.61) | |
Revenue per Share |
5.19 | 4.81 | 7.10 | 3.99 | |
Operating CF per Share |
0.40 | 0.38 | 0.50 | (0.17) | |
Capex per Share |
(0.11) | (0.10) | (0.16) | (0.09) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
1.39% | (2.22%) | (4.91%) | (11.82%) |
Columns are period end dates